ImmuCell Corporation Restricted Cash and Cash Equivalents, Noncurrent
ImmuCell Corporation (ICCC) had Restricted Cash and Cash Equivalents, Noncurrent of $1.40 million as of 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2020-11-12
- 2020-09-30: Restricted Cash and Cash Equivalents, Noncurrent $1.40M.
- 2020-06-30: Restricted Cash and Cash Equivalents, Noncurrent $1.40M.
- 2020-03-31: Restricted Cash and Cash Equivalents, Noncurrent $1.40M.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2020-09-30 | $1.40M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.40M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $1.40M 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |